Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Table of Contents

August 1, 1989; Volume 143,Issue 3

ARTICLES

  • You have accessRestricted access
    Fine specificity of T cell recognition of the same peptide in association with different I-A molecules.
    S J Brett, K B Cease, C S Ouyang and J A Berzofsky
    J Immunol August 1, 1989, 143 (3) 771-779;
  • You have accessRestricted access
    Stimulation of PIP2 hydrolysis by aluminum fluoride in resting T cell subsets of normal and autoimmune-prone lpr mice.
    K M Coggeshall and A Altman
    J Immunol August 1, 1989, 143 (3) 780-786;
  • You have accessRestricted access
    Transferrin receptor synthesis is an early event in B cell activation.
    J Futran, J D Kemp, E H Field, A Vora and R F Ashman
    J Immunol August 1, 1989, 143 (3) 787-792;
  • You have accessRestricted access
    Clonogenic potential of murine CD4+8+ thymocytes. Direct demonstration using a V beta 6-specific proliferative stimulus in Mlsa mice.
    R C Howe and H R MacDonald
    J Immunol August 1, 1989, 143 (3) 793-797;
  • You have accessRestricted access
    CD44 contributes to T cell activation.
    S Huet, H Groux, B Caillou, H Valentin, A M Prieur and A Bernard
    J Immunol August 1, 1989, 143 (3) 798-801;
  • You have accessRestricted access
    Analysis of the interaction of peptide hen egg white lysozyme (34-45) with the I-Ak molecule.
    L E Lambert and E R Unanue
    J Immunol August 1, 1989, 143 (3) 802-807;
  • You have accessRestricted access
    A functional role for signal transduction via the cytoplasmic domains of MHC class II proteins.
    Y St-Pierre, N Nabavi, Z Ghogawala, L H Glimcher and T H Watts
    J Immunol August 1, 1989, 143 (3) 808-812;
  • You have accessRestricted access
    Immunomodulatory activity of staphylococcal enterotoxin-B. The induction of an I-J-restricted suppressor factor.
    D D Taub, Y S Lin, S C Hu and T J Rogers
    J Immunol August 1, 1989, 143 (3) 813-820;
  • You have accessRestricted access
    The immune response and the eye. III. Anterior chamber-associated immune deviation can be adoptively transferred by serum.
    T A Ferguson, J D Hayashi and H J Kaplan
    J Immunol August 1, 1989, 143 (3) 821-826;
  • You have accessRestricted access
    Host resistance to cyclosporine induced syngeneic graft-versus-host disease. Requirement for two distinct lymphocyte subsets.
    A C Fischer, M K Laulis, L Horwitz, W E Beschorner and A Hess
    J Immunol August 1, 1989, 143 (3) 827-832;
  • You have accessRestricted access
    Platelet-derived growth factor and IL-1 interactions in rheumatoid arthritis. Regulation of synoviocyte proliferation, prostaglandin production, and collagenase transcription.
    G K Kumkumian, R Lafyatis, E F Remmers, J P Case, S J Kim and R L Wilder
    J Immunol August 1, 1989, 143 (3) 833-837;
  • You have accessRestricted access
    Selective abrogation of alloreactivity via priming in the presence of aphidicolin, a specific inhibitor of DNA polymerase.
    S Morecki, S Slavin and S A Ben-Sasson
    J Immunol August 1, 1989, 143 (3) 838-843;
  • You have accessRestricted access
    Functional and phenotypic alterations in T cell subsets during the course of MAIDS, a murine retrovirus-induced immunodeficiency syndrome.
    H C Morse 3rd, R A Yetter, C S Via, R R Hardy, A Cerny, K Hayakawa, A W Hugin, M W Miller, K L Holmes and G M Shearer
    J Immunol August 1, 1989, 143 (3) 844-850;
  • You have accessRestricted access
    Identification of a widely distributed 90-kDa glycoprotein that is homologous to the Hermes-1 human lymphocyte homing receptor.
    S T Pals, F Hogervorst, G D Keizer, T Thepen, E Horst and C C Figdor
    J Immunol August 1, 1989, 143 (3) 851-857;
  • You have accessRestricted access
    CD8+CD4- lymphocyte lines can harbor the AIDS virus in vitro.
    H Tsubota, D J Ringler, M Kannagi, N W King, K R Solomon, J J MacKey, D G Walsh and N L Letvin
    J Immunol August 1, 1989, 143 (3) 858-863;
  • You have accessRestricted access
    Activation of normal human B cells through their antigen receptor induces membrane expression of IL-1 alpha and secretion of IL-1 beta.
    J Y Bonnefoy, M C Denoroy, O Guillot, C L Martens and J Banchereau
    J Immunol August 1, 1989, 143 (3) 864-869;
  • You have accessRestricted access
    IL-2 regulation of tyrosine kinase activity is mediated through the p70-75 beta-subunit of the IL-2 receptor.
    D K Ferris, J Willette-Brown, J R Ortaldo and W L Farrar
    J Immunol August 1, 1989, 143 (3) 870-876;
  • You have accessRestricted access
    Inhibition of early murine hemopoietic progenitor cell proliferation after in vivo locoregional administration of transforming growth factor-beta 1.
    H Goey, J R Keller, T Back, D L Longo, F W Ruscetti and R H Wiltrout
    J Immunol August 1, 1989, 143 (3) 877-880;
  • You have accessRestricted access
    Production of multiple lymphokines by the A20.1 B cell lymphoma after cross-linking of membrane Ig by immobilized anti-Ig.
    L B Justement, J Kreiger and J C Cambier
    J Immunol August 1, 1989, 143 (3) 881-889;
  • You have accessRestricted access
    Modulation of mRNA levels for urinary- and tissue-type plasminogen activator and plasminogen activator inhibitors 1 and 2 in human fibroblasts by interleukin 1.
    J B Michel and T Quertermous
    J Immunol August 1, 1989, 143 (3) 890-895;
  • You have accessRestricted access
    Synergistic interactions of IL-1 and IL-6 in T cell activation. Mitogen but not antigen receptor-induced proliferation of a cloned T helper cell line is enhanced by exogenous IL-6.
    H Mizutani, L T May, P B Sehgal and T S Kupper
    J Immunol August 1, 1989, 143 (3) 896-901;
  • You have accessRestricted access
    IL-4-responsive human helper T cell clones are resistant to growth inhibition by tumor necrosis factor-alpha.
    G P Pawelec, A Rehbein, K Schaudt and F W Busch
    J Immunol August 1, 1989, 143 (3) 902-906;
  • You have accessRestricted access
    Production of lymphokine mRNA by CD45R+ and CD45R- helper T cells from human peripheral blood and by human CD4+ T cell clones.
    M Salmon, G D Kitas and P A Bacon
    J Immunol August 1, 1989, 143 (3) 907-912;
  • You have accessRestricted access
    Involvement of class II MHC molecules in the LPS-induction of IL-1/TNF secretions by human monocytes. Quantitative differences at the polymorphic level.
    P Santamaria, R C Gehrz, M K Bryan and J J Barbosa
    J Immunol August 1, 1989, 143 (3) 913-922;
  • You have accessRestricted access
    Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cells.
    J C Carel, B Frazier, T J Ley and V M Holers
    J Immunol August 1, 1989, 143 (3) 923-930;
  • You have accessRestricted access
    Bivalent binding of an anti-CD3 antibody to Jurkat cells induces association of the T cell receptor complex with the cytoskeleton.
    N Marano, D Holowka and B Baird
    J Immunol August 1, 1989, 143 (3) 931-938;
  • You have accessRestricted access
    IL-2, a lectin with specificity for high mannose glycopeptides.
    A P Sherblom, N Sathyamoorthy, J M Decker and A V Muchmore
    J Immunol August 1, 1989, 143 (3) 939-944;
  • You have accessRestricted access
    Specific molecular interaction between the insulin receptor and a D product of MHC class I.
    S Verland, M Simonsen, S Gammeltoft, H Allen, R A Flavell and L Olsson
    J Immunol August 1, 1989, 143 (3) 945-951;
  • You have accessRestricted access
    Eosinophil cationic protein cDNA. Comparison with other toxic cationic proteins and ribonucleases.
    R L Barker, D A Loegering, R M Ten, K J Hamann, L R Pease and G J Gleich
    J Immunol August 1, 1989, 143 (3) 952-955;
  • You have accessRestricted access
    Human peripheral lymphocyte growth regulation and response to phorbol esters is linked to synthesis and phosphorylation of the cytosolic protein, prosolin.
    H L Cooper, E McDuffie and R Braverman
    J Immunol August 1, 1989, 143 (3) 956-963;
  • You have accessRestricted access
    Platelet-activating factor (PAF) enhances tumor necrosis factor production by alveolar macrophages. Prevention by PAF receptor antagonists and lipoxygenase inhibitors.
    C Dubois, E Bissonnette and M Rola-Pleszczynski
    J Immunol August 1, 1989, 143 (3) 964-970;
  • You have accessRestricted access
    Plasminogen activator and prostaglandin E2 levels in human synovial fibroblasts. Differential stimulation by synovial activator and other cytokines.
    T Leizer and J A Hamilton
    J Immunol August 1, 1989, 143 (3) 971-978;
  • You have accessRestricted access
    Human eosinophil cytotoxicity-enhancing factor. Purification, physical characteristics, and partial amino acid sequence of an active polypeptide.
    D S Silberstein, M H Ali, S L Baker and J R David
    J Immunol August 1, 1989, 143 (3) 979-983;
  • You have accessRestricted access
    Characterization of B lymphocytes present in the demyelinating lesions induced by Theiler's virus.
    E Cash, A Bandeira, S Chirinian and M Brahic
    J Immunol August 1, 1989, 143 (3) 984-988;
  • You have accessRestricted access
    Characteristics of protective immunity in mice induced by drug-attenuated larvae of Schistosoma mansoni. Antigen localization and antibody responses.
    A P Mountford, P S Coulson, N Saunders and R A Wilson
    J Immunol August 1, 1989, 143 (3) 989-995;
  • You have accessRestricted access
    Dual action of anti-sporozoite antibodies in vitro.
    S Nudelman, L Rénia, Y Charoenvit, L Yuan, F Miltgen, R L Beaudoin and D Mazier
    J Immunol August 1, 1989, 143 (3) 996-1000;
  • You have accessRestricted access
    Amastigote and epimastigote stage-specific components of Trypanosoma cruzi characterized by using monoclonal antibodies. Purification and molecular characterization of an 83-kilodalton amastigote protein.
    A A Pan and D McMahon-Pratt
    J Immunol August 1, 1989, 143 (3) 1001-1008;
  • You have accessRestricted access
    T cell receptor delta gene organization and expression in normal and leukemic natural killer cells.
    A Biondi, P Allavena, V Rossi, R Bassan, T Barbui, E Champagne, T W Mak, M D Minden, A Rambaldi and A Mantovani
    J Immunol August 1, 1989, 143 (3) 1009-1014;
  • You have accessRestricted access
    Somatostatin gene expression in the thymus gland.
    P J Fuller and K Verity
    J Immunol August 1, 1989, 143 (3) 1015-1017;
  • You have accessRestricted access
    Mutation of 3' splice sites in two different class I genes results in different usage of cryptic splice sites.
    M L Hedley, J Forman and P W Tucker
    J Immunol August 1, 1989, 143 (3) 1018-1025;
  • You have accessRestricted access
    Expression of mutant H-2d proteins encoded by class I genes which alternatively process the 5' end of their transcripts.
    M L Hedley, K Ozato, J Maryanski, P W Tucker and J Forman
    J Immunol August 1, 1989, 143 (3) 1026-1031;
  • You have accessRestricted access
    Induction of c-fos and c-myc expression during B cell activation by IL-4 and immunoglobulin binding ligands.
    M J Klemsz, L B Justement, E Palmer and J C Cambier
    J Immunol August 1, 1989, 143 (3) 1032-1039;
  • You have accessRestricted access
    A novel VHDJH to JH joining that induces H chain production in an Ig-null immature B cell line.
    T Komori, H Sugiyama and S Kishimoto
    J Immunol August 1, 1989, 143 (3) 1040-1045;
  • You have accessRestricted access
    Role of transcriptional termination in the regulation of mu mRNA expression in B lymphocytes.
    E A Weiss, A Michael and D Yuan
    J Immunol August 1, 1989, 143 (3) 1046-1052;
  • You have accessRestricted access
    Tumor idiotype vaccines. VI. Synergistic anti-tumor effects with combined "internal image" anti-idiotypes and chemotherapy.
    J J Chen, Y Saeki, L F Shi and H Köhler
    J Immunol August 1, 1989, 143 (3) 1053-1057;
  • You have accessRestricted access
    Relationship between target cell recognition and temporal fluctuations in intracellular Ca2+ of human NK cells.
    B S Edwards, H A Nolla and R R Hoffman
    J Immunol August 1, 1989, 143 (3) 1058-1065;
  • You have accessRestricted access
    Inhibition of lymphokine-activated killer- and natural killer-mediated cytotoxicities by neutrophils.
    H Y Shau and S H Golub
    J Immunol August 1, 1989, 143 (3) 1066-1072;

LETTERS TO THE EDITOR

  • You have accessRestricted access
    Human leukocyte differentiation antigens.
    A Bernard and V Horejsi
    J Immunol August 1, 1989, 143 (3) 1073;
Back to top
PreviousNext
PreviousNext

This Issue

The Journal of Immunology
Vol. 143, Issue 3
1 Aug 1989
  • Table of Contents
  • Table of Contents (PDF)
Sign up for alerts

Jump to

  • ARTICLES
  • LETTERS TO THE EDITOR
  • Highlights
  • Most Cited
  • Most Read
Loading
Immunodominant AH1 Antigen-Deficient Necroptotic, but Not Apoptotic, Murine Cancer Cells Induce Antitumor Protection
Osteoclasts Derive Predominantly from Bone Marrow–Resident CX3CR1+ Precursor Cells in Homeostasis, whereas Circulating CX3CR1+ Cells Contribute to Osteoclast Development during Fracture Repair
Intracellular IL-1 Receptor Antagonist Isoform 1 Released from Keratinocytes upon Cell Death Acts as an Inhibitor for the Alarmin IL-1α
Polysaccharide Capsules Equip the Human Symbiont Bacteroides thetaiotaomicron to Modulate Immune Responses to a Dominant Antigen in the Intestine
Natural and Induced Tolerogenic Dendritic Cells
Cutting Edge: IL-6–Driven Immune Dysregulation Is Strictly Dependent on IL-6R α-Chain Expression

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • Public Access
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606